Key Takeaways DOCS' Q1 revenues rose 15% to $145.9M with adjusted EBITDA margin of 55$26M Pathway deal adds clinical AI depth, boosting accuracy and physician trust.Doximity (DOCS) entered fiscal 2026 with stronger-than-expected results, reporting first-quarter revenues of $145.9 million (up 15% year over year) and an adjusted EBITDA margin of 55%. But the spotlight of the quarter wasn’t just financial outperformance ...